Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells (Q73299715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Cutting edge: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

26 December 2023

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

26 December 2023

author name string

Thomas Schüler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Thomas Blankenstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

4427-4431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

The central role of CD4(+) T cells in the antitumor immune response

2 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen

26 December 2023

2

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

26 December 2023

3

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Tumor rejection by disturbing tumor stroma cell interactions

26 December 2023

4

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

26 December 2023

5

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

26 December 2023

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

26 December 2023

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells

26 December 2023

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

26 December 2023

9

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL

26 December 2023

11

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance

26 December 2023

12

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

T cell receptor antagonist peptides induce positive selection

26 December 2023

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Tumours can act as adjuvants for humoral immunity

26 December 2023

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

26 December 2023

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

26 December 2023

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

26 December 2023

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells

26 December 2023

20

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Cross-presentation, dendritic cells, tolerance and immunity

26 December 2023

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens

26 December 2023

22

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

26 December 2023

23

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation

26 December 2023

24

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Constitutive class I-restricted exogenous presentation of self antigens in vivo

26 December 2023

25

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

26 December 2023

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant

26 December 2023

27

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

26 December 2023

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway

26 December 2023

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4427

26 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12707316%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference